Showing results (281-290 of 612) with videos related to

Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 15, 2026
Establishing humoral immunity to rabies in a person with multiple sclerosis through booster vaccination: A case reportD Dinov, P Hardeman, J Tessier, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 2, 2025
Metabolic labeling kinetics of brain-derived 24S-hydroxycholesterol in blood in multiple sclerosis: Effects of treatment with the remyelinating antibody rHIgM22Mahalakshmi Shankaran, Kelvin W Li, Hussein A Mohammed, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 8, 2020
Anti-JCV antibody index does not change during ocrelizumab-treatmentTorge Rempe, Aaron Carlson, Augusto Miravalle, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 28, 2020
Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment studyChristine Poulos, Craig Wakeford, Elizabeth Kinter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 1, 2020
Survival following the placement of gastrostomy tube in patients with multiple sclerosisLisa Grandidge, Chayaporn Chotiyarnwong, Sean White, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 15, 2021
Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patientsFriederike Held, Sudhakar Reddy Kalluri, Achim Berthele, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 15, 2021
Forearm muscle mitochondrial capacity and resting oxygen uptake: Relationship to symptomatic fatigue in persons with multiple sclerosisElizabeth M DePauw, Mitra Rouhani, Aidan M Flanagan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 28, 2021
Influence of equipment changes on MRI measures of brain atrophy and brain microstructure in a placebo-controlled trial of ibudilast in progressive multiple sclerosisKen Sakaie, Janel K Fedler, Jon W Yankey, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 21, 2020
Physical activity monitoring to assess disability progression in multiple sclerosisCharlotte M Stuart, Aravinthan Varatharaj, Janine Domjan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 23, 2021
Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosisZara A Ioannides, Peter A Csurhes, Andrew Swayne, et al.
Pageof 62